Related Experiment Video
Updated: Aug 9, 2026

12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Methicillin-resistant Staphylococcus aureus infections in children
1Department of Pediatrics, University of Missouri-Kansas City School of Medicine, USA.
Missouri Medicine
|April 4, 2006
Summary
Methicillin-resistant Staphylococcus aureus (MRSA) is a growing concern, causing skin infections and serious invasive diseases in the US. Treatment depends on local resistance patterns and infection severity, especially in pediatric cases.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Resistance
- Bacterial Pathogenesis
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant and increasing public health challenge in the United States.
- MRSA infections manifest commonly as skin and soft tissue infections but can progress to severe invasive disease affecting any organ system.
Purpose of the Study:
- To review the epidemiology of MRSA infections in children.
- To describe the clinical features associated with pediatric MRSA infections.
- To outline current treatment considerations for MRSA in pediatric populations.
Main Methods:
- Literature review of epidemiological data on MRSA.
- Analysis of clinical case studies and reports on MRSA infections in children.
- Synthesis of current treatment guidelines and antimicrobial susceptibility data.
Main Results:
- MRSA is an emerging pathogen in both pediatric and adult populations across the US.
- Skin and soft tissue infections are the most frequent presentation, but invasive MRSA disease can occur.
- Empirical treatment strategies must account for regional antimicrobial susceptibility patterns and disease severity.
Conclusions:
- Understanding MRSA epidemiology and clinical presentations is crucial for effective management in children.
- Treatment decisions for pediatric MRSA require careful consideration of local resistance data and infection severity.
- This review provides essential information for clinicians managing MRSA infections in pediatric patients.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...